Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Canadian Imperial Venture Corp. (CQV.H) says Ikänik Farms Inc.’s wholly owned, Colombian subsidiary Pideka SAS, has completed the first commercial sale and exportation of THC to Mexico for use in Formula Magistral
  • Ikänik was successfully able to obtain all certifications and permissions needed to legalize the process
  • Ikänik will provide cannabinoid solutions through formula magistral in LATAM to treat epilepsy, cancer, pain, nausea, anxiety, insomnia and support the growing demand of the EU marketplace
  • President of Ikänik Farms, Borja Sanz de Madrid said the company would like to thank both governments for their roles.
  • Canadian Imperial Venture Corp. opened at C$0.28 per share

Ikänik Farms’ Colombian subsidiary Pideka SAS, has completed the first commercial sale and exportation of THC to Mexico for use in Formula Magistral.

President of Ikänik Farms, International, Borja Sanz de Madrid said the company would like to thank both governments for their roles.

“We are excited to participate in this groundbreaking moment for the cannabis industry and the countries of Mexico and Colombia, as the first Colombian company to export psychoactive cannabis oil to Mexico.”

Working hand in hand with both governments, Ikänik was successfully able to obtain all certifications and permissions needed to legalize the process and complete its 15 step procedure required to export psychoactive cannabis products from Colombia to Mexico.

Ikänik Farms legalized the exportation process of psychoactive cannabis in Colombia, making it the first company to successfully complete a “commercial sale” for export.

Looking ahead, Ikänik will provide cannabinoid solutions through formula magistral in LATAM to treat epilepsy, cancer, pain, nausea, anxiety, insomnia and support the growing demand of the EU marketplace.

“We are proud to have participated in this historic moment and look forward to our growth servicing the global cannabis market,” said Brian Baca, CEO of Ikänik Farms.

Through development of its Colombian operations, Ikänik aims to support global pharmaceutical demand for a variety of cannabis products. Ikänik’s leadership brings decades of expertise in R&D, cultivation, retail, branding, and corporate finance with the ambition to build the most iconic “seed-to-sale”, “MNO” Multi-National Operator. Ikänik Farms’ operations are currently located in Colombia and California.

Canadian Imperial Venture Corp. opened at C$0.28 per share.

More From The Market Herald

" Revive (CSE:RVV) gets FDA OK for Bucillamine trials to treat COVID-19

Revive Therapeutics (RVV), a cannabis and psychedelic healthcare company has received feedback from the U.S. FDA to help advance Bucillamine.

" West Island Brands (CSE:WIB) releases Q1 financial results

West Island Brands (WIB) has released unaudited first quarter 2022 financial results.

" Sweet Earth (CSE:SE) signs LOI to acquire strategic targets from ST Group

Sweet Earth Holdings (SE) has signed an LOI with ST Group to explore the amalgamation of certain partner assets and companies into Sweet